USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Trends in Nanomedicine (TechVision)
Nano-based science paving the precision medicine era
30-Dec-2015
Global
Technology Research
D6C0-01-00-00-00
HC02409-GL-TR_16531
The continued development of new treatments associated with the demographic trends and public health considerations is remarkable. Nanotechnology has been identified as one most relevant key enabling technologies of the last ten years, significantly impacting on many different biomedical developments in a broad spectrum of applications therapeutics, diagnostics, theranostics, medical imaging, regenerative medicine, life sciences research and biosciences, among many others. In fact, nanomedicine is present in all therapeutic areas, exhibiting a perceptible and extensive impact in the treatment and diagnosis of some most concerned diseases.
Innovation in nanomedicine fields has played a major role in the improvement of both length and quality of life during the present decade, appreciably advocated to reduce the disease burden for individuals and the society through completely new or improved diagnostic and therapeutic methods. Groundbreaking advances in the scientific understanding of the underlying mechanisms of disease are paving the way for nanomedicine on precision medicine topics.
Frost & Sullivan (www.frost.com/techvision) identified an unprecedented behavior in terms of innovation in nanomedicine fields, with notable acceptance in diagnostics, therapeutics, companion diagnostics, regenerative medicine, and many other applications that are undoubtedly linked to the concept of precision medicine. Nanomedicine enables personalized medicine approaches in many ways. As an instance, nano-based diagnostic tests or nano-imaging diagnosis may help to the stratification of patients and thereby to guarantee a most personalized, patient-centered therapy. In addition, clinical protocols become simpler, more efficient and less costly.
Research Scope
Research Scope (continued)
Research Methodology
Key Findings
Industry Value Chain and Business Model
Core Technology Applications
Technology Evolution
Core Growth Opportunities
Technology Synergy and Nanobiotechnology
Technology Roadmap
Industry Drivers and Restraints
Industry Technical and Business Challenges
Market Drivers and Restraints
Technology Drivers and Restraints
Porter’s Five Forces Analysis
Nanomedicine Innovation Model
Nanomedicine Innovation Model (continued)
Nanomedicine Innovation Model (continued)
Nanomedicines Application Focus
Nanomedicines Therapeutics Focus
Nanomedicines Diagnostics Focus
Nanomedicines Regenerative Medicine Focus
Nanomedicine Multiple Segmentation
Nanomedicines Principal Industry Facts
Nanomedicines Principal Industry Facts (continued)
Nanomedicine Development Pipeline
Nanomedicine Products by Developmental Phase
Global Nanomedicine Market
Global Nanomedicine Market (continued)
Global Nanomedicine Market (continued)
Product Pipeline
Product Pipeline (continued)
Product Pipeline (continued)
Product Pipeline (continued)
Product Pipeline (continued)
Product Pipeline (continued)
Nanomedicine Marketed Products
Nanomedicine Marketed Products (continued)
Nanomedicine Marketed Products (continued)
Key Companies in North America
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in Europe
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Asia Pacific
Key Companies in Asia Pacific (continued)
Intellectual Property
Intellectual Property (continued)
Intellectual Property (continued)
Multicriteria Approach for Benchmarking
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Final Remarks
Legal Disclaimer
Key Contacts
Key Contacts (continued)
Key Contacts (continued)
Key Contacts (continued)
Key Contacts (continued)
Key Contacts (continued)
Key Contacts (continued)
Intellectual Property Sources
Key Patents
Key Patents (continued)
Key Patents (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.